Abstract:Background: Group 2 innate lymphoid cells (ILC2s) are critical mediators of type 2 respiratory inflammation, releasing IL-5 and IL-13 and promoting the pulmonary eosinophilia associated with allergen provocation. Although ILC2s have been shown to promote eosinophil activities, the role of eosinophils in group 2 innate lymphoid cell (ILC2) responses is less well defined. Objective: We sought to investigate the role of eosinophils in activation of ILC2s in models of allergic asthma and in vitro. Methods: Inducible eosinophil-deficient mice were exposed to allergic respiratory inflammation models of asthma, such as ovalbumin or house dust mite challenge, or to innate models of type 2 airway inflammation, such as inhalation of IL-33. Eosinophil-specific IL-4/13-deficient mice were used to address the specific roles for eosinophil-derived cytokines. Direct cell interactions between ILC2s and eosinophils were assessed by in vitro culture experiments. Results: Targeted depletion of eosinophils resulted in significant reductions of total and IL-5+ and IL-13+ lung ILC2s in all models of respiratory inflammation. This correlated with reductions in IL-13 levels and mucus in the airway. Eosinophil-derived IL-4/13 was necessary for both eosinophil and ILC2 accumulation in lung in allergen models. In vitro, eosinophils released soluble mediators that induced ILC2 proliferation and G protein-coupled receptor-dependent chemotaxis of ILC2s. Coculture of ILC2s and IL-33-activated eosinophils resulted in transcriptome changes in both ILC2s and eosinophils, suggesting potential novel reciprocal interactions. Conclusion: These studies demonstrate that eosinophils play a reciprocal role in ILC2 effector functions as part of both adaptive and innate type 2 pulmonary inflammatory events.

Pulmonary environmental cues drive group 2 innate lymphoid cell dynamics in mice and humans

Angiotensin II Enhances Group 2 Innate Lymphoid Cell Responses Via AT1a During Airway Inflammation.

Lung Dysfunction in a Mouse Model of Inflammation is Dependent on T-cell-independent IL-13 Expression (54.18)

ILC2-derived LIF licences progress from tissue to systemic immunity

The Origin and Role of Innate Lymphoid Cells in the Lung

Maturation and specialization of group 2 innate lymphoid cells through the lung-gut axis

Group 2 innate lymphoid cells protect lung endothelial cells from pyroptosis in sepsis

Neural Regulation of Interactions Between Group 2 Innate Lymphoid Cells and Pulmonary Immune Cells

Cutting Edge: CCR8 Signaling Regulates IL-25- and IL-33-Responsive Skin Group 2 Innate Lymphoid Cell Migration and Function

Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice

Sensing and signaling of immunogenic extracellular RNAs restrain group 2 innate lymphoid cell-driven acute lung inflammation and airway hyperresponsiveness

Guards at the gate: physiological and pathological roles of tissue-resident innate lymphoid cells in the lung

Nr4a1 marks a distinctive ILC2 activation subset in the mouse inflammatory lung

Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells

Lipid droplet messengers

The E3 Ligase VHL Controls Lung Inflammation by Regulating Epithelium-ILC2 Cross-talk

Tissue-specific pathways extrude activated ILC2s to disseminate type 2 immunity

Group 2 Innate Lymphoid Cells Exhibit Tissue-Specific Dynamic Behaviour During Type 2 Immune Responses

Cross-talk between ILC2 and Gata3 high T regs locally constrains adaptive type 2 immunity

Identification of Two Migratory Colon ILC2 Populations Differentially Expressing IL-17A and IL-5/IL-13

The Role of Group 3 Innate Lymphoid Cells in Lung Infection and Immunity